Buscar resultados de ensayos clínicos
Hemoglobinuria - 76 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry Condición: Paroxysmal Nocturnal Hemoglobinuria Fecha: 2011-04-15 |
Completed |
Nombre del estudio: Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria Condición: Paroxysmal Hemoglobinuria, Nocturnal Fecha: 2005-08-11 Intervenciones: Drug: Eculizumab |
Completed |
Nombre del estudio: The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH) Condición: Hemoglobinuria, Paroxysmal Fecha: 2008-07-23 |
Completed |
Nombre del estudio: Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria Condición: Paroxysmal Hemoglobinuria Fecha: 2002-06-14 |
Completed |
Nombre del estudio: E07-001: Safety and Efficacy Extension Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients Condición: Paroxysmal Nocturnal Hemoglobinuria Fecha: 2010-08-30 Intervenciones: Drug: Eculizumab Each vial contains 30 mL of 10 mg/mL eculizumab; dose of 900 mg intravenous every 14 da |
Recruiting |
Nombre del estudio: A Treatment Study of ACH-0144471 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Condición: Paroxysmal Nocturnal Hemoglobinuria (PNH) Fecha: 2017-02-01 Intervenciones: Drug: ACH-0144471 ACH-0144471 will be administered to all patients enrolled in the study. |
Completed |
Nombre del estudio: C07-001: Safety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients Condición: Paroxysmal Nocturnal Hemoglobinuria Fecha: 2010-08-30 Intervenciones: Biological: Eculizumab Subjects were treated with open label Eculizumab and following the dose described |
Active, not recruiting |
Nombre del estudio: An Open-Label, Intrapatient, Dose-Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxysmal Nocturnal Hemoglobinuria Condición: Paroxysmal Nocturnal Hemoglobinuria (PNH) Fecha: 2015-11-02 Intervenciones:
|
Recruiting |
Nombre del estudio: Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of RO7112689 in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria Condición: Paroxysmal Hemoglobinuria, Nocturnal Fecha: 2016-11-01 Intervenciones:
|
Recruiting |
Nombre del estudio: Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) Condición: Paroxysmal Nocturnal Haemoglobinuria (PNH) Fecha: 2015-09-10 Intervenciones: Drug: Coversin Patients enrolled in this protocol will initially be treated with an ablating dose of Cov |